Investor

Investor

Financial History

 

  2008 2007 2006 2005 2004 2003 2002 2001 2000 1999
Cochlear Implant System Sales(units) 18,228 15,947 12,901 10,802 9,306 9,328 7,845 6,482 4,941 4,128
Income Statement ($m)
Total Revenue 601.7 559.4 452.3 349.0 282.8 306.1 255.0 220.1 144.2 127.2
R&D Expenditure***
78.4 63.8 56.7 44.6 44.5 37.0 37.7** 27.7 20.9* 13.5
EBITDA 193.3 170.9 130.2 96.8 54.9 87.9 56.2 49.0 33.0 25.8
EBIT 167.3 150.2 111.5 82.5 45.5 80.1 51.5 45.5 30.4 23.1
Profit after Income Tax 115.2 100.1 80.0 59.6 36.8 58.2 40.1 31.2 20.2 16.3
Core Earnings 123.7 107.6 86.4 60.8 36.8 58.2 40.1 31.2 20.2 16.3
Balance Sheet ($m)
Total Assets 607.9 585.7 545.9 502.7 264.5 230.6 160.4 129.0 93.8 82.9
Total Liabilities 288.6 324.9 336.1 348.0 119.0 110.9 85.0 73.6 50.9 48.9
Statistics
EPS (cents) 208.1 182.9 146.8 110.1 68.2 110.0 76.6 60.2 39.6 32.3
Core EPS (cents) 223.4 196.5 158.4 112.4 68.2 110.0 76.6 60.2 39.6 32.3
DPS (cents) 150.0 125.0 100.0 80.0 79.0 77.0 51.0 41.0 30.0 20.0
Other Data
Closing Share Price ($) 43.65 61.00 54.63 39.20 22.72 32.30 34.05 39.00 28.76 12.00
Market Capitalisation as at 30 June ($m) 2,423 3,341 2,985 2,123 1,231 1,714 1,788 2,029 1,469 606
Number of Employees 1,789 1,655 1,100 982 816 814 722 639 543 432


Financial amounts for 2005 to 2008 are in accordance with AIFRS. Financial amounts for 1998 to 2004 are in accordance with previous GAAP.
* Excludes $4.4m acquisition from Philips Hearing Implants NV.
** Excludes $5.2m acquisition of core technology from Implex AG Hearing Technology.
***excluding Capitalisation and Amortisation